Please use this identifier to cite or link to this item: http://repository.i3l.ac.id/jspui/handle/123456789/266
Title: Investigation of Anti-Alzheimer’s Activity of Coriander (Coriandrum sativum L.) Leaves Extract: Insight into Antioxidant Activity and GABAARs
Authors: Rebecca, Jeannifer
Keywords: Alzheimer’s Disease
Coriander leaves extract
Antioxidant activity
RT-qPCR
Issue Date: 28-Aug-2021
Publisher: Indonesia International Institute for Life Sciences
Series/Report no.: PHA 21-001;T202109044
Abstract: Alzheimer’s Disease (AD) is most common form of dementia and a neurodegenerative disease characterized by significant decline in cognitive ability that interferes with daily activities. This disease is characterized by accumulation of amyloid-β, NFTs, and oxidative stress in the brain of AD patient that leads to inflammation and neurotoxicity. Around 50 million people worldwide suffer from dementia, with nearly 10 million new cases diagnosed each year. Most of the medication available are only relieving the symptoms of AD, but not curing, stopping, or preventing AD. Thus, discovery of effective medication for AD is urgently required. Previous studies reported that leaf of coriander is potential plants to improve memory and slow down AD progression. In patient suffering from AD, decreased in GABA neurotransmitter and the postsynaptic GABAARs were altered, causing disruption in dynamic balance. By modulating GABAARs in AD, the dynamic balance of excitatory and inhibitory effect possibly maintained. The aim of this study is to evaluate the antioxidant activity of coriander leaves extracted in 80% ethanol by using DPPH free radical scavenging method and study the gene expression on ddY mice of Alzheimer’s like disease by using RT-qPCR to investigate the expression of GABAARs subunit, which are GABRAα1, GABRAγ1, and GABRAδ. The mice were received ten consecutive days treatment of Donepezil (4 mg/kg) and Coriander Extract (200 mg/kg, 400 mg/kg, and 600 mg/kg) orally. On the tenth day, scopolamine was administered to induce memory impairment like AD and then behavioural test, Y maze and novel object recognition (NOR) test, were conducted. After that, the mice were sacrificed and its hippocampus was collected. From the hippocampus region, RNA was extracted using GENEzol, Once the RNA was obtained, the purity and integrity were assessed using NanoDrop and gel electrophoresis. After that, cDNA was synthesis using RevertAid Kit, and then the expression of GABAARs subunits was assessed using RT-qPCR QuantiNova SYBR Green. The findings are coriander leaves extract was prepared by 3 times maceration of pulverized coriander leaves in 80% Ethanol, yielded in 28.47% which is low. Coriander leaves extracted in 80% vi ethanol exert antioxidant activity, with IC50 value of 42.164 μg/ml However, it is not as potent as ascorbic acid, who has IC50 value of 4.127±1.81 μg/ml. Moreover, the RNA extracted from the mice’s hippocampus have a generally good purity, with A260/280 ratio ranging from 1.6-2.02 and high integrity with distinct bands formation on the agarose gel electrophoresis. The primers used for RT-qPCR are GABRAA1, GABRG1, and GABRAD, with an acceptable efficiency of 103.09%, 97.23%, and 95.67%, respectively, where the standard is ranging from 90-110%, meaning that the PCR condition is sufficient to produce an efficient PCR reaction. The primers are also a specific primer that able to target the desired gene in the animal model of ddY mice. Unfortunately, due to technical difficulties the RotorGene PCR machine the gene expression evaluation of GABRA1, GABRG1, and GABRAD could not be carried out. It is shown from the findings that coriander leaves extract exerts antioxidant activity, which can be used to slow down or to prevent AD progression. Furthermore, better understanding of the content and the mechanism of action of active compounds found in coriander leaves extract are required to discover exact mechanism on mediating anti-Alzheimer activity.
URI: http://repository.i3l.ac.id/jspui/handle/123456789/266
Appears in Collections:Pharmacy

Files in This Item:
File Description SizeFormat 
T202109044_Pharmacy_Jeannifer Rebecca.pdf
  Restricted Access
Full text1.31 MBAdobe PDFView/Open Request a copy
Cover.pdfCover1.26 MBAdobe PDFView/Open
Abstract.pdfAbstract1.22 MBAdobe PDFView/Open
Chapter 1.pdfChapter 11.21 MBAdobe PDFView/Open
References.pdfReferences1.21 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.